Matthew M. Laughon

12.7k total citations · 2 hit papers
162 papers, 6.4k citations indexed

About

Matthew M. Laughon is a scholar working on Pulmonary and Respiratory Medicine, Pediatrics, Perinatology and Child Health and Surgery. According to data from OpenAlex, Matthew M. Laughon has authored 162 papers receiving a total of 6.4k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Pulmonary and Respiratory Medicine, 67 papers in Pediatrics, Perinatology and Child Health and 52 papers in Surgery. Recurrent topics in Matthew M. Laughon's work include Neonatal Respiratory Health Research (101 papers), Congenital Diaphragmatic Hernia Studies (44 papers) and Neuroscience of respiration and sleep (31 papers). Matthew M. Laughon is often cited by papers focused on Neonatal Respiratory Health Research (101 papers), Congenital Diaphragmatic Hernia Studies (44 papers) and Neuroscience of respiration and sleep (31 papers). Matthew M. Laughon collaborates with scholars based in United States, United Kingdom and Canada. Matthew M. Laughon's co-authors include Carl Bose, Reese H. Clark, P. Brian Smith, Daniel K. Benjamin, Christoph P. Hornik, Peter G. Davis, Alan Leviton, Elizabeth N. Allred, L.J. Van Marter and Andrea Trembath and has published in prestigious journals such as SHILAP Revista de lepidopterología, American Journal of Respiratory and Critical Care Medicine and PEDIATRICS.

In The Last Decade

Matthew M. Laughon

156 papers receiving 6.3k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach

2019 630 citations Erik A. Jensen, Kevin Dysart et al. American Journal of Respiratory and Critical Care Medicine profile →
Bronchopulmonary dysplasia

2019 622 citations Matthew M. Laughon et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Matthew M. Laughon United States	43	4.3k	2.6k	2.1k	1.3k	1.0k	162	6.4k
Brenda B. Poindexter United States	39	4.1k 1.0×	1.9k 0.7×	2.8k 1.3×	1.9k 1.5×	770 0.8×	117	7.3k
Carlo Dani Italy	41	3.4k 0.8×	1.5k 0.6×	2.1k 1.0×	1.0k 0.8×	973 1.0×	272	6.0k
C. Michael Cotten United States	43	5.0k 1.1×	1.7k 0.7×	4.7k 2.3×	2.3k 1.8×	751 0.7×	160	10.1k
W.E. Benitz United States	43	2.8k 0.6×	1.1k 0.4×	2.7k 1.3×	2.4k 1.9×	725 0.7×	194	7.2k
Ömer Erdeve Türkiye	36	1.6k 0.4×	888 0.3×	1.1k 0.5×	1.4k 1.1×	313 0.3×	257	4.1k
Christoph P. Hornik United States	35	1.5k 0.3×	915 0.4×	1.2k 0.6×	1.6k 1.3×	151 0.1×	250	4.7k
Douglas K. Richardson United States	38	3.2k 0.7×	960 0.4×	2.8k 1.4×	1.2k 0.9×	564 0.6×	99	5.5k
Kenneth Poole United States	15	1.7k 0.4×	788 0.3×	1.1k 0.5×	531 0.4×	354 0.4×	37	2.7k
Arno van Heijst Netherlands	34	1.9k 0.4×	1.7k 0.7×	1.1k 0.5×	799 0.6×	134 0.1×	147	3.6k
Billie Lou Short United States	37	1.6k 0.4×	1.3k 0.5×	576 0.3×	843 0.7×	221 0.2×	132	3.6k

Countries citing papers authored by Matthew M. Laughon

Since Specialization

Citations

This map shows the geographic impact of Matthew M. Laughon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Laughon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Laughon more than expected).

Fields of papers citing papers by Matthew M. Laughon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Laughon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Laughon. The network helps show where Matthew M. Laughon may publish in the future.

Co-authorship network of co-authors of Matthew M. Laughon

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Laughon. A scholar is included among the top collaborators of Matthew M. Laughon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Laughon. Matthew M. Laughon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Thompson, Elizabeth J., Daniel González, Julie B. Dumond, et al.. (2025). Population Pharmacokinetics of Caffeine in Infants with Hypoxic‐Ischemic Encephalopathy: A Phase I, Dose‐Escalating Trial. The Journal of Clinical Pharmacology. 65(7). 933–943. 1 indexed citations

Török, Rachel D., Robert A. Gardner, Jennifer S. Li, et al.. (2024). Correlating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia. American Journal of Perinatology. 41(16). 2206–2213. 3 indexed citations

Bamat, Nicolas A., Justine Shults, Yun Li, et al.. (2023). Diuretic Tolerance to Repeated-Dose Furosemide in Infants Born Very Preterm with Bronchopulmonary Dysplasia. The Journal of Pediatrics. 266. 113813–113813. 2 indexed citations

Bamat, Nicolas A., Elizabeth J. Thompson, Rachel G. Greenberg, et al.. (2022). Association between postmenstrual age and furosemide dosing practices in very preterm infants. Journal of Perinatology. 42(4). 461–467. 2 indexed citations

Jackson, Wesley, Daniel González, P. Brian Smith, et al.. (2021). Safety of sildenafil in extremely premature infants: a phase I trial. Journal of Perinatology. 42(1). 31–36. 7 indexed citations

Sanderson, Keia, Bradley A. Warady, William A. Carey, et al.. (2021). Mortality Risk Factors among Infants Receiving Dialysis in the Neonatal Intensive Care Unit. The Journal of Pediatrics. 242. 159–165. 5 indexed citations

Westreich, Daniel, Matthew M. Laughon, David M. Stamilio, et al.. (2020). Association of chorioamnionitis and patent ductus arteriosus in a national U.S. cohort. Journal of Perinatology. 41(1). 119–125. 9 indexed citations

Salerno, Sara, Andrea N. Edginton, Matthew M. Laughon, et al.. (2020). Physiologically‐Based Pharmacokinetic Modeling Characterizes the CYP3A‐Mediated Drug‐Drug Interaction Between Fluconazole and Sildenafil in Infants. Clinical Pharmacology & Therapeutics. 109(1). 253–262. 31 indexed citations

Jackson, Wesley, Genevieve Taylor, Nicolas A. Bamat, et al.. (2020). Outcomes associated with surfactant in more mature and larger premature infants with respiratory distress syndrome. Journal of Perinatology. 40(8). 1171–1177. 2 indexed citations

10.

McNaull, Peggy, Kanecia O. Zimmerman, Daniel K. Benjamin, et al.. (2020). Wide range of perioperative drugs and doses used in inguinal hernia repairs for premature infants. Journal of Perinatology. 41(3). 577–581. 1 indexed citations

11.

Salerno, Sara, Yuting Liao, Wesley Jackson, et al.. (2020). Association between Nephrotoxic Drug Combinations and Acute Kidney Injury in the Neonatal Intensive Care Unit. The Journal of Pediatrics. 228(3). 213–219. 38 indexed citations

12.

González, Daniel, Matthew M. Laughon, P. Brian Smith, et al.. (2019). Population pharmacokinetics of sildenafil in extremely premature infants. British Journal of Clinical Pharmacology. 85(12). 2824–2837. 18 indexed citations

13.

Bamat, Nicolas A., Haresh Kirpalani, Chris Feudtner, et al.. (2019). Medication use in infants with severe bronchopulmonary dysplasia admitted to United States children’s hospitals. Journal of Perinatology. 39(9). 1291–1299. 43 indexed citations

14.

Jensen, Erik A., Kevin Dysart, Marie G. Gantz, et al.. (2019). The Diagnosis of Bronchopulmonary Dysplasia in Very Preterm Infants. An Evidence-based Approach. American Journal of Respiratory and Critical Care Medicine. 200(6). 751–759. 630 indexed citations breakdown →

15.

Jackson, Wesley, T. Michael O’Shea, Elizabeth N. Allred, et al.. (2018). Risk factors for chronic lung disease and asthma differ among children born extremely preterm. Pediatric Pulmonology. 53(11). 1533–1540. 18 indexed citations

16.

Jackson, Wesley, Genevieve Taylor, David T. Selewski, et al.. (2018). Association between furosemide in premature infants and sensorineural hearing loss and nephrocalcinosis: a systematic review. SHILAP Revista de lepidopterología. 4(1). 17 indexed citations

17.

Taylor, Genevieve, Wesley Jackson, Christoph P. Hornik, et al.. (2018). Surfactant Administration in Preterm Infants: Drug Development Opportunities. The Journal of Pediatrics. 208. 163–168. 12 indexed citations

18.

Long, D. Leann, Amy H. Herring, Matthew M. Laughon, et al.. (2016). Center Variation in the Delivery of Indicated Late Preterm Births. American Journal of Perinatology. 33(10). 1008–1016. 2 indexed citations

19.

Zimmerman, Kanecia O., Christoph P. Hornik, Lawrence Ku, et al.. (2015). Sedatives and Analgesics Given to Infants in Neonatal Intensive Care Units at the End of Life. The Journal of Pediatrics. 167(2). 299–304.e3. 14 indexed citations

20.

Turner, K. C., Paolo Manzoni, Daniel K. Benjamin, et al.. (2012). Fluconazole Pharmacokinetics and Safety in Premature Infants. Current Medicinal Chemistry. 19(27). 4617–4620. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact